ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2026
Clinical significance of ADHD traits in central disorders of hypersomnolence.
Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimAttention-deficit/hyperactivity disorder (ADHD) is increasingly recognized as a potential comorbidity in central disorders of hypersomnolence (CDHs), including narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH). This study aimed to characterize ADHD traits within these CDH populations and evaluate their association with daily functioning.
methodsAdult participants (≥ 18 years old) with a clinical diagnosis of NT1, NT2, or IH were enrolled. Matched controls were recruited through an online platform. All participants completed validated self-report questionnaires: the Adult ADHD Self-Report Scale (ASRS), Epworth Sleepiness Scale (ESS), EuroQol 5-Dimension (EQ-5D), Kessler Psychological Distress Scale (K6), and the World Health Organization Health and Work Performance Questionnaire (WHO-HPQ).
resultsThe study included 175 patients (NT1: n = 58; NT2: n = 46; IH: n = 71) and 350 controls. ADHD traits were significantly more prevalent among patients with CDH (24%) than among controls (7%), with odds ratios of 5.11 for NT1, 5.08 for NT2, and 3.87 for IH. The ADHD prevalence was not significantly different across CDH types and was predominantly inattentive. Elevated ASRS scores in CDH were not associated with increased ESS score. Among CDH patients, not ASRS but K6 was correlated with the EQ-5D score.
conclusionAlthough ADHD traits were commonly seen in CDH, their impact on functional outcomes looked to be limited. Psychological distress driven by sleepiness in CDH is more closely related to daytime dysfunctions than ADHD traits. This may suggest the importance of prioritizing hypersomnolence management, even in patients exhibiting ADHD characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.